Literature DB >> 20224549

Phosphatidylinositol-(4,5)-bisphosphate enables efficient secretion of HIV-1 Tat by infected T-cells.

Fabienne Rayne1, Solène Debaisieux, Hocine Yezid, Yea-Lih Lin, Clément Mettling, Karidia Konate, Nathalie Chazal, Stefan T Arold, Martine Pugnière, Françoise Sanchez, Anne Bonhoure, Laurence Briant, Erwann Loret, Christian Roy, Bruno Beaumelle.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) transcription relies on its transactivating Tat protein. Although devoid of a signal sequence, Tat is released by infected cells and secreted Tat can affect uninfected cells, thereby contributing to HIV-1 pathogenesis. The mechanism and the efficiency of Tat export remained to be documented. Here, we show that, in HIV-1-infected primary CD4(+) T-cells that are the main targets of the virus, Tat accumulates at the plasma membrane because of its specific binding to phosphatidylinositol-4,5-bisphosphate (PI(4,5)P(2)). This interaction is driven by a specific motif of the Tat basic domain that recognizes a single PI(4,5)P(2) molecule and is stabilized by membrane insertion of Tat tryptophan side chain. This original recognition mechanism enables binding to membrane-embedded PI(4,5)P(2) only, but with an unusually high affinity that allows Tat to perturb the PI(4,5)P(2)-mediated recruitment of cellular proteins. Tat-PI(4,5)P(2) interaction is strictly required for Tat secretion, a process that is very efficient, as approximately 2/3 of Tat are exported by HIV-1-infected cells during their lifespan. The function of extracellular Tat in HIV-1 infection might thus be more significant than earlier thought.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20224549      PMCID: PMC2868572          DOI: 10.1038/emboj.2010.32

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  62 in total

1.  Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages.

Authors:  Elena Chertova; Oleg Chertov; Lori V Coren; James D Roser; Charles M Trubey; Julian W Bess; Raymond C Sowder; Eugene Barsov; Brian L Hood; Robert J Fisher; Kunio Nagashima; Thomas P Conrads; Timothy D Veenstra; Jeffrey D Lifson; David E Ott
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

2.  Comparative analysis of HIV-1 Tat variants.

Authors:  Sergio Pantano; Paolo Carloni
Journal:  Proteins       Date:  2005-02-15

3.  Identification of a signal peptide for unconventional secretion.

Authors:  Edmond Dupont; Alain Prochiantz; Alain Joliot
Journal:  J Biol Chem       Date:  2007-01-22       Impact factor: 5.157

4.  Acid-triggered membrane insertion of Pseudomonas exotoxin A involves an original mechanism based on pH-regulated tryptophan exposure.

Authors:  Jocelyn Méré; Juliette Morlon-Guyot; Anne Bonhoure; Laurent Chiche; Bruno Beaumelle
Journal:  J Biol Chem       Date:  2005-03-30       Impact factor: 5.157

Review 5.  Phosphoinositides in cell regulation and membrane dynamics.

Authors:  Gilbert Di Paolo; Pietro De Camilli
Journal:  Nature       Date:  2006-10-12       Impact factor: 49.962

6.  Phosphatidylinositol-(4,5)-bisphosphate regulates sorting signal recognition by the clathrin-associated adaptor complex AP2.

Authors:  Stefan Höning; Doris Ricotta; Michael Krauss; Kira Späte; Barbara Spolaore; Alison Motley; Margaret Robinson; Carol Robinson; Volker Haucke; David J Owen
Journal:  Mol Cell       Date:  2005-05-27       Impact factor: 17.970

7.  PI(3,4,5)P3 and PI(4,5)P2 lipids target proteins with polybasic clusters to the plasma membrane.

Authors:  Won Do Heo; Takanari Inoue; Wei Sun Park; Man Lyang Kim; Byung Ouk Park; Thomas J Wandless; Tobias Meyer
Journal:  Science       Date:  2006-11-09       Impact factor: 47.728

8.  Quantitative analysis of the binding of ezrin to large unilamellar vesicles containing phosphatidylinositol 4,5 bisphosphate.

Authors:  Guillaume Blin; Emmanuel Margeat; Kévin Carvalho; Catherine A Royer; Christian Roy; Catherine Picart
Journal:  Biophys J       Date:  2007-09-07       Impact factor: 4.033

9.  PtdIns5P activates the host cell PI3-kinase/Akt pathway during Shigella flexneri infection.

Authors:  Caroline Pendaries; Hélène Tronchère; Laurence Arbibe; Joelle Mounier; Or Gozani; Lewis Cantley; Michael J Fry; Frédérique Gaits-Iacovoni; Philippe J Sansonetti; Bernard Payrastre
Journal:  EMBO J       Date:  2006-02-16       Impact factor: 11.598

10.  Active caspase-1 is a regulator of unconventional protein secretion.

Authors:  Martin Keller; Andreas Rüegg; Sabine Werner; Hans-Dietmar Beer
Journal:  Cell       Date:  2008-03-07       Impact factor: 41.582

View more
  68 in total

1.  Expressed cell-penetrating peptides can induce a bystander effect, but passage through the secretory pathway reduces protein transduction activity.

Authors:  Ying Shen; William Yu; John G Hay; Harald Sauthoff
Journal:  Mol Ther       Date:  2010-12-21       Impact factor: 11.454

2.  Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein.

Authors:  Tory P Johnson; Karan Patel; Kory R Johnson; Dragan Maric; Peter A Calabresi; Rodrigo Hasbun; Avindra Nath
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-29       Impact factor: 11.205

3.  Novel neuroprotective GSK-3β inhibitor restricts Tat-mediated HIV-1 replication.

Authors:  Irene Guendel; Sergey Iordanskiy; Rachel Van Duyne; Kylene Kehn-Hall; Mohammed Saifuddin; Ravi Das; Elizabeth Jaworski; Gavin C Sampey; Svetlana Senina; Leonard Shultz; Aarthi Narayanan; Hao Chen; Benjamin Lepene; Chen Zeng; Fatah Kashanchi
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

Review 4.  Defining the molecular mechanisms of HIV-1 Tat secretion: PtdIns(4,5)P2 at the epicenter.

Authors:  Anthony R Mele; Jamie Marino; Kenneth Chen; Vanessa Pirrone; Chris Janetopoulos; Brian Wigdahl; Zachary Klase; Michael R Nonnemacher
Journal:  Traffic       Date:  2018-04-30       Impact factor: 6.215

5.  Assembly and replication of HIV-1 in T cells with low levels of phosphatidylinositol-(4,5)-bisphosphate.

Authors:  Kazuaki Monde; Vineela Chukkapalli; Akira Ono
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

6.  The EGF epidermal growth factor counteracts Tat modulation of human endogenous retroviruses of the W family in astrocytes.

Authors:  Elena Uleri; Claudia Piu; Maurizio Caocci; Gabriele Ibba; Caterina Serra; Antonina Dolei
Journal:  J Neurovirol       Date:  2017-05-04       Impact factor: 2.643

7.  Molecular mechanisms in the dramatic enhancement of HIV-1 Tat transduction by cationic liposomes.

Authors:  Guan-Han Li; Wenxue Li; Russell J Mumper; Avindra Nath
Journal:  FASEB J       Date:  2012-03-23       Impact factor: 5.191

8.  Key steps in unconventional secretion of fibroblast growth factor 2 reconstituted with purified components.

Authors:  Julia P Steringer; Sascha Lange; Sabína Čujová; Radek Šachl; Chetan Poojari; Fabio Lolicato; Oliver Beutel; Hans-Michael Müller; Sebastian Unger; Ünal Coskun; Alf Honigmann; Ilpo Vattulainen; Martin Hof; Christian Freund; Walter Nickel
Journal:  Elife       Date:  2017-07-19       Impact factor: 8.140

9.  Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART.

Authors:  Barbara Ensoli; Stefania Bellino; Antonella Tripiciano; Olimpia Longo; Vittorio Francavilla; Simone Marcotullio; Aurelio Cafaro; Orietta Picconi; Giovanni Paniccia; Arianna Scoglio; Angela Arancio; Cristina Ariola; Maria J Ruiz Alvarez; Massimo Campagna; Donato Scaramuzzi; Cristina Iori; Roberto Esposito; Cristina Mussini; Florio Ghinelli; Laura Sighinolfi; Guido Palamara; Alessandra Latini; Gioacchino Angarano; Nicoletta Ladisa; Fabrizio Soscia; Vito S Mercurio; Adriano Lazzarin; Giuseppe Tambussi; Raffaele Visintini; Francesco Mazzotta; Massimo Di Pietro; Massimo Galli; Stefano Rusconi; Giampiero Carosi; Carlo Torti; Giovanni Di Perri; Stefano Bonora; Fabrizio Ensoli; Enrico Garaci
Journal:  PLoS One       Date:  2010-11-11       Impact factor: 3.240

10.  The basic domain of HIV-tat transactivating protein is essential for its targeting to lipid rafts and regulating fibroblast growth factor-2 signaling in podocytes isolated from children with HIV-1-associated nephropathy.

Authors:  Xuefang Xie; Anamaris M Colberg-Poley; Jharna R Das; Jinliang Li; Aiping Zhang; Pingtao Tang; Marina Jerebtsova; J Silvio Gutkind; Patricio E Ray
Journal:  J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.